Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
right Nastro keep on dreaming pump lol
A good pump))) now it will fall back during the day at $ 4.00
sold at 5. 27 today for about a 10% profit in 9 business days.
glad i rode out the scary dip
It bounced off Fib resistance @ 4.90.
4.75 there was 2 doji candles... and the 50 DAY Moving average... i bought in then. I think the 3 day tankage after was possible just some random panic n maybe a few bigger players taking profits... look at the 6 month chart.
I play technicals. I will possibly sell tomorrow however this could run for a few days.
as for a short squeeze. i don't see why not LOL. but there wasn't a great deal of shorting the last 5 to 6 days. but maybe there were some longer shorters out there
shortanalytics.com
LOL. glad i only listen to the voices in my head... LOL :)
So why are you here?
This was one of the better pump and dumps I've seen in awhile, lots of bag holders in this POS, glad I'm not one of them.
ive been follolwing this for a year now. This thing is poopin!! wow, but only 20 Million shares!! if this drug gets approved, this will skyrocket, problem is, IF and WHEN
ive been follolwing this for a year now. This thing is poopin!! wow, but only 20 Million shares!! if this drug gets approved, this will skyrocket, problem is, IF and WHEN
How'd you like it yesterday? We're luggage on this deal. Shoulda bailed...
50 DAY MA holding :)
Also a nice doji today
Triple bottom
I'm a technical trader. all info already priced in
Bought at 4.71 previously.... sold at 5.12
Bought back partial position today at 4.74 ... i'm already down money so u may be right .... we shall see.
i'm hoping to sell for 4.99 and make a 5% gain in 2 days or less :)
I'm long on NO stocks
Bought a position today at average of 4.75 ....might be adding tomorrow. 4.67 Moving average hopefully will hold :)
Been bearish for the last year or so.
As of the list dated Oct. 14, 2013, Zalicus is no longer listed as a deficient company.
https://listingcenter.nasdaqomx.com/assets/deldefopenreport.pdf
$ZLCS http://stks.co/bmNo Last Friday ZLCS was still in non compliance list. We will see it will be removed after market close today!
Don't know about a shareholder's vote, but ZLCS has done this type of thing in the past:
"..And, if there is a near-term need for funding, that may not be such a bad thing, as ZLCS tends to raise money in conjunction with big milestones and key drug developments."
http://www.smallcapnetwork.com/Zalicus-Inc-NASDAQ-ZLCS-Right-Stock-Wrong-Time/s/via/10/article/view/p/mid/2/id/106/
So the precedent is there.
Did the shareholders vote"NO" for dilution?
Yes, Orphan Drug status will reduce the cost of the Ph 3, but if they have good news and the share price pops up, I would be surprised if they did not take the opportunity to raise funds on the move.
$ZLCS Next Monday both Z160 P2 trials complete! Corrigan is going to reveal to very positive results anytime.
Detailed Bullish from American Bulls.
ZLCS reversed trend today. Needs to confirm but definitely caught a bid, up over 6%.
Risky, but with the crucial data due in short order, potential for great trade or long-term investment.
http://americanbulls.com/members/Default.Aspx?lang=en
the company has enough money and orphan designated p3 requires 1/4 the money to carry out.
I agree. After the emotion of the run up and the RS, I decided to wait until after results and subsequent dilution to fund Ph 3. Yes I expect positive results, but don't want to absorb 20-30% dilution in the process. I'll let it marinate after the next offering and watch it settle back down before I step in. I'll wait for a good price after the dust settles and will have less risk.
Terrible buy IMO. It's still hitting lower lows. Next low will be 4.30 then 4. Mark my post.
the timing was right
I wanted to get back in fannie so I sold here. I think this could very well run for a few days.
I took profits at 5.12
Sorry I don't use this very much. But I think it may possibly run the next 2 days.
I may buy in again though. I'm a swing trader.
now did you take your profit or are you letting it run
Was I right or was I right?
I should have asked if you were ST trading or holding more for the LT.
The slow Stoch is oversold, yes, and the 50 day should provide support. If not watch out, IMO.
Pure speculation and I may have bought in too early but we shall see.
50 DAY MA support at 4.63
Fast stochastics about to cross if we close above 4.75
Volume down today.... it is Friday however
So far today the low of today is higher than the low of yesterday.
Like I said, I may have pulled the trigger a bit quick but time will tell.
What indication did you have that it would pop? Looks like knife-catching.
Bought in today :) looking for a nice pop
They want the funds to buy this stock just like what happened to$AEGR
Sold out here and most of my other plays yesterday. I'm mostly in cash right now and watching our leaders deadlocked on re opening the gov and raising the debt ceiling.
Just too much risk here for my blood.
Took a $7,000 plus loss on this one in just 2 weeks (ouch)!
The both Z160 trials will be finished next week! The positive results will come anytime!
Sentiment: Strong Buy
In my opinion there was no need for a R/S, ZLCS WAS FLYING UP just fine by itself due to the latest news. One of the explanations would be is that they know something is not going well with one of the clinical trials. Assuming the above opinion, management knows that the price would plummet down again causing the delisting from NASDAQ.
The other scenario which is better than delisting but not great for shareholders is the need to raise capital by an offering of common shares, either way I think sometime before December if no good news come out we are going to see the 3s. Hope. For the best, be prepare for the worst.
I agree
IMO this is a great opportunity to load up on cheap shares
$30,000.00 buy at one shot. Someone know something?
Looks like turnaround here IMO
Close 6.50 EOW be great
Followers
|
75
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2191
|
Created
|
08/12/07
|
Type
|
Free
|
Moderators |
http://finance.yahoo.com/q/ks?s=ZLCS
http://www.form4oracle.com/company?cik=0001135906&ticker=crxx
Zalicus Inc., a biopharmaceutical company, engages in the development of drug candidates focusing on the treatment of pain and inflammation. The company's clinical and preclinical product candidates for pain, inflammation, and other central nervous system disorders include Synavive (CRx-102), a novel dissociated glucocorticoid product candidate, which has completed Phase II clinical trials in subjects with knee osteoarthritis, to treat immuno-inflammatory disorders; Prednisporin (FOV1101), a topical ophthalmic drug candidate containing low doses of the glucocorticoid prednisolone acetate and the immunosuppressant cyclosporine A; N-type and T-type calcium channel blockers for the treatment of chronic pain; and CRx-601, a formulation of carbidopa and levodopa for the treatment of Parkinson's disease. It is also developing CRx-401 for Type 2 diabetes; CRx-191 and CRx-197 for psoriasis. It has a research collaboration and license agreement with the Novartis Institutes of Biomedical Research; a collaboration agreement with PGxHealth, LLC for the development of ATL313, an adenosine A2A receptor agonist compound owned by PGxHealth; collaboration agreement with Mallinckrodt Inc., Fovea Pharmaceuticals SA, and National Institutes of Allergy and Infectious Diseases; and a cooperative research and development agreement with the United States Army Medical Research Institute for Infectious Diseases. The company was formerly known as CombinatoRx, Incorporated and changed its name to Zalicus Inc. on September 9, 2010. Zalicus Inc. was founded in 2000 and is based in Cambridge, Massachusetts.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |